## **Core Concept**
Double blinding in clinical trials is a method used to reduce bias by concealing the treatment assignments from both the participants and the researchers. This technique helps in minimizing the influence of subjective factors on the outcomes of the study.

## **Why the Correct Answer is Right**
The correct answer, , refers to observer bias or investigator bias. Double blinding primarily aims to eliminate or reduce this type of bias. When researchers are aware of which participants are receiving the experimental treatment and which are receiving the control treatment, their expectations or behaviors can inadvertently influence the measurement of outcomes. By keeping the treatment assignments unknown to both participants and researchers, double blinding helps ensure that the assessment of outcomes is more objective.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because double blinding does not directly address selection bias. Selection bias occurs during the recruitment phase and can be addressed through randomization.
- **Option B:** This option is incorrect as double blinding does not specifically target performance bias related to unequal provision of care. While it helps reduce performance bias by ensuring that researchers treat all participants similarly, it does not eliminate all sources of performance bias.
- **Option C:** This option might seem related but is not directly addressed by double blinding in the context usually implied by the question.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that double blinding is a crucial methodological feature that enhances the validity of clinical trials by reducing bias. However, not all studies can be double-blinded (e.g., surgical vs. medical therapy), and researchers use other methods like single blinding or statistical adjustments to address limitations.

## **Correct Answer:** . Investigator or observer bias.